30.04.2015 • NewsDede WillamsBASFcapacity expansion

BASF Trials MDI Precursor Production at Chongqing

BASF has begun trial operations at its 400,000 t/y mononitrobenzene plant at Chongqing, in western China. The new facility will feed the group's integrated MDI complex at the same location. Investment costs for the entire project are pegged at €860 million.

In addition to mononitrobenzene, the site will produce 300,000 t/y of aniline, 400,000 t/y of crude MDI and will also have an MDI splitter with a capacity of 400,000 t/y.

Located in the Chongqing Changshou Chemical Industrial Park, the complex, initially planned to go on stream in 2010, took three and a half years to be approved by Chinese authorities. A planned start-up in 2014 was delayed further by BASF's differences with officials over an increase in gas prices.

MDI is an important component for polyurethanes. BASF is building a new Polyurethane Solutions Systems House at Chongqing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation